Appointments
With the retirement of Elias Zerhouni as Head of Global R&D, Sanofi had to find a suitable replacement and believes it has found the man in...
Immunomedics hasn’t had the most straight forward year, its $2 billion deal with Seattle Genetics was scuppered by activist investors, which...
Frequency Therapeutics is a biotech with big ideas and it has made a big appointment to back up those ideas, by appointing William Chin...
Ipsen is set to expand its executive leadership team with the announcement of two new recruitments: Dr Ivana Magovčević-Liebisch will join the...
Verona Pharma has revealed that it is to part ways with its Chief Medical Officer at the end of the month. Dr Kenneth Newman will leave the...
Gilead has announced that Dr Norbert Bischofberger, its Chief Scientific Officer (CSO), Executive Vice President of Research and Development and a...
Dr John C Reed, Roche’s Head of Pharma Research and Early Development (pRED), is set to leave the company due to personal reasons, it has...
Takeda has announced that its Chief Financial Officer, James Kehoe, has decided to move on from the company to take up the same position...
MannKind, the California-based biotech, announced that David Kendall would be joining its team as Chief Medical Officer and would be...
Stada has revealed its new CEO as Peter Goldschmidt, the current head of North American operations at Novartis’ generics and biosimilars unit...
